|
Great news! Please share: The groundbreaking phase II study of DFMO to PREVENT relapse is now open at the NMTRC site at Children's Mercy Hospital in Kansas City with Dr. Kathleen Neville.
http://www.vai.org/Research/Labs/Neuroblastoma-Translational-Research/Neuroblastoma-Medulloblastoma/Clinical-Trials/Phase-II-DFMO.aspx Promising Research revealed at the ANR Conference recently held in Toronto.
http://www.fiercebiotechresearch.com/story/cleveland-biolabs-drug-chemo-kill-neuroblastomas-mice/2012-06-25 |
|
|
